BOSTON - (Business Wire) Halloran Consulting Group (Halloran), a firm that specializes in clinical development services for emerging and established life sciences companies, today announced the appointments of Laura Araujo, as Senior Director of Quality Management, and Tina Forrister, as Senior Associate for Training and Development.
“Cost-effective quality and education programs continue to be a priority for any size company that is developing new drugs,” said Laurie Halloran, president and CEO of Halloran Consulting Group. “We are thrilled to have Laura and Tina on board, as they are integral to the expansion of our practice areas and bring valuable knowledge and expertise to our firm and to our clients.”
Laura Araujo brings over 20 years of experience in quality assurance, technology management and software development in the biopharmaceutical industries. At Halloran, she will focus her efforts on providing clients with quality management system implementation, software development, validation and training services. Prior to joining Halloran Consulting, Ms. Araujo was Vice President of Quality at Perceptive Informatics, the leader in clinical trial business support applications and services, and before that she was Vice President, Quality, IT and Customer Support at Clinsoft (formerly Domain Pharma).
Tina Forrister brings 12 years of expertise in clinical research training, clinical project and program management, and monitoring. Prior to joining Halloran Consulting, Ms. Forrister was Senior Trainer at Schering–Plough Corporation, where she developed and delivered programs on clinical project management, global trial management and best practices in the US and abroad. Her efforts at Halloran will focus on the expansion of the Training Practice, developing and delivering customized programs to life sciences companies as well as through Halloran’s public course offerings.
About Halloran Consulting Group
Halloran Consulting Group (Halloran) specializes in clinical development services for biotech, pharmaceutical and medical device companies. Halloran partners with clients to help them evaluate, hire and manage their CRO, while building organizational infrastructure, regulatory and quality frameworks. Halloran applies wisdom from hundreds of clinical trials and regulatory submissions to ensure capital efficient drug development for sponsor companies.
For more information, visit www.hallorancg.com or contact Margaret Sullivan at US +1 617.254.7860 or msullivan@hallorancg.com.
Halloran Consulting Group
Margaret Sullivan, +1 617-254-7860
msullivan@hallorancg.com.
